Citations (150)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cindy J. Choy & Clifford E. Berkman. (2016) A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1690-1693.
Read now
Read now
Awatef
Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Ahmed Banasr, Yassine Nouira & Ridha Oueslati. (2014) PSMA/PSA RATIO EVALUATED BY IMMUNOHISTOCHEMISTRY MAY IMPROVE DIAGNOSIS OF PROSTATE CANCER. Journal of Immunoassay and Immunochemistry 35:1, pages 48-59.
Read now
Read now
Articles from other publishers (148)
Xinxing Du, Yanhao Dong, Jiazhou Liu, Yun Su, Yinjie Zhu, Jiahua Pan, Baijun Dong, Ruohua Chen, Jianjun Liu, Zhen Tong, Kenneth J. Pienta, Steven P. Rowe, Liang Dong & Wei Xue. (2023) Baseline PSMA‐PET/CT as a predictor of PSA persistence following radical prostatectomy in high‐risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy. The Prostate.
Crossref
Crossref
Yuan Hu, Peng Wang & Wenli Dai. (2023) Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Marcel Lindemann, Ana Oteiza, Montserrat Martin-Armas, Yngve Guttormsen, Angel Moldes-Anaya, Rodrigo Berzaghi, Trond Velde Bogsrud, Tore Bach-Gansmo, Rune Sundset & Mathias Kranz. (2022) Glioblastoma PET/MRI: kinetic investigation of [18F]rhPSMA-7.3, [18F]FET and [18F]fluciclovine in an orthotopic mouse model of cancer. European Journal of Nuclear Medicine and Molecular Imaging 50:4, pages 1183-1194.
Crossref
Crossref
Jose M. Prieto & Mohd Mukrish Mohd Hanafi. (2023) Advances in Molecular Regulation of Prostate Cancer Cells by Top Natural Products of Malaysia. Current Issues in Molecular Biology 45:2, pages 1536-1567.
Crossref
Crossref
Amelie Heesch, Lars Ortmanns, Jochen Maurer, Elmar Stickeler, Sabri E. M. Sahnoun, Felix M. Mottaghy & Agnieszka Morgenroth. (2023) The Potential of PSMA as a Vascular Target in TNBC. Cells 12:4, pages 551.
Crossref
Crossref
Yuchen Pei, Chang Liu, Mingtao Feng, Liangdong Li, Changshuai Zhou, Lei Chen, Xin Hu, Shaoli Song, Yiqun Cao & Yang Gao. (2023) The clinical application of 68Ga-PSMA PET/CT and regulating mechanism of PSMA expression in patients with brain metastases of lung cancer. Translational Oncology 28, pages 101616.
Crossref
Crossref
Jiayu Zhang, Tong Lu, Shiqi Lu, Shuaijun Ma, Donghui Han, Keying Zhang, Chao Xu, Shaojie Liu, Lunbiao Gan, Xinjie Wu, Fa Yang, Weihong Wen & Weijun Qin. (2023) Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Computational and Structural Biotechnology Journal 21, pages 665-676.
Crossref
Crossref
Kaylon Kelvin dos Santos Godê, Felipe Alves Mourato, Antônio Felipe de França Sales, Paulo José de Almeida Filho, Simone Cristina Soares Brandão & Lauro Wichert-Ana. (2022) Thyroid incidentalomas in PSMA PET/CT: a systematic review and meta-analysis. Clinical and Translational Imaging.
Crossref
Crossref
Michel Kmeid, Young Nyun Park, Taek Chung, Georgi Lukose, Luz Sullivan, Rupinder Brar & Hwajeong Lee. (2022) PSMA Immunohistochemistry in Hepatic Neoplasms. American Journal of Surgical Pathology 46:12, pages 1688-1699.
Crossref
Crossref
Mohamed Ameen, Laksshman Sundaram, Mengcheng Shen, Abhimanyu Banerjee, Soumya Kundu, Surag Nair, Anna Shcherbina, Mingxia Gu, Kitchener D. Wilson, Avyay Varadarajan, Nirmal Vadgama, Akshay Balsubramani, Joseph C. Wu, Jesse M. Engreitz, Kyle Farh, Ioannis Karakikes, Kevin C. Wang, Thomas Quertermous, William J. Greenleaf & Anshul Kundaje. (2022) Integrative single-cell analysis of cardiogenesis identifies developmental trajectories and non-coding mutations in congenital heart disease. Cell 185:26, pages 4937-4953.e23.
Crossref
Crossref
Ioana M. Marinescu, Manuel Rogg, Simon Spohn, Moritz von Büren, Marius Kamps, Cordula A. Jilg, Elena Fountzila, Kyriaki Papadopoulou, Lara Ceci, Alisa Bettermann, Juri Ruf, Matthias Benndorf, Sonja Adebahr, Daniel Zips, Anca L. Grosu, Christoph Schell & Constantinos Zamboglou. (2022) Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters. Radiation Oncology 17:1.
Crossref
Crossref
Antonia Digklia, Sarah Boughdad, Krisztian Homicsko, Clarisse Dromain, Mounir Trimech, Ana Dolcan, Solange Peters, John Prior & Niklaus Schaefer. (2022)
First communication on the efficacy of combined
177
Lutetium-PSMA with immunotherapy outside prostate cancer
. Journal for ImmunoTherapy of Cancer 10:10, pages e005383.
Crossref
Crossref
Shuxian An, Gang Huang, Jianjun Liu & Weijun Wei. (2022) PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers. European Journal of Nuclear Medicine and Molecular Imaging 49:12, pages 3973-3976.
Crossref
Crossref
Sadakatali S. Gori, Ajit G. Thomas, Arindom Pal, Robyn Wiseman, Dana V. Ferraris, Run-duo Gao, Ying Wu, Jesse Alt, Takashi Tsukamoto, Barbara S. Slusher & Rana Rais. (2022) D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II. Pharmaceutics 14:10, pages 2018.
Crossref
Crossref
Arsalan Tariq, Amy E. McCart Reed, Andrew Morton, Sima Porten, Ian Vela, Elizabeth D. Williams, John W. Yaxley, Peter C. Black & Matthew J. Roberts. (2022) Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic Implications. European Urology Focus 8:5, pages 1256-1269.
Crossref
Crossref
Alessio Rizzo, Sara Dall’Armellina, Daniele Antonio Pizzuto, Germano Perotti, Luca Zagaria, Valerio Lanni, Giorgio Treglia, Manuela Racca & Salvatore Annunziata. (2022) PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?. Cancers 14:16, pages 4039.
Crossref
Crossref
Beshara Sheehan, Antje Neeb, Lorenzo Buroni, Alec Paschalis, Ruth Riisnaes, Bora Gurel, Veronica Gil, Susana Miranda, Mateus Crespo, Christina Guo, Juan Jiménez Vacas, Ines Figueiredo, Ana Ferreira, Jon Welti, Wei Yuan, Suzanne Carreira, Adam Sharp & Johann de Bono. (2022) Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. Clinical Cancer Research 28:14, pages 3104-3115.
Crossref
Crossref
Alyaa Sadeq, Sharjeel Usmani, Abdulredha A. Esmail, Wael Fathallah, Mahmoud A. Alfeeli & Fahad Marafi. (2022) Incremental Value of 18F-PSMA-1007 PET/CT in Detection of Metastatic Renal Cell Carcinoma to the Brain. Clinical Nuclear Medicine 47:7, pages 627-628.
Crossref
Crossref
Scott M. Thompson, Garima Suman, Michael S. Torbenson, Zong‐Ming E. Chen, Danielle E. Jondal, Anurima Patra, Eric C. Ehman, James C. Andrews, Chad J. Fleming, Brian T. Welch, Anil N. Kurup, Lewis R. Roberts, Kymberly D. Watt, Mark J. Truty, Sean P. Cleary, Rory L. Smoot, Julie K. Heimbach, Nguyen H. Tran, Amit Mahipal, Jun Yin, Tyler Zemla, Chen Wang, Zachary Fogarty, Mark Jacobson, Bradley J. Kemp, Sudhakar K. Venkatesh, Geoffrey B. Johnson, David A. Woodrum & Ajit H. Goenka. (2021) PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and 68Ga‐PSMA‐11 PET Using Cyclotron‐Produced 68Ga. Hepatology Communications 6:5, pages 1172-1185.
Crossref
Crossref
Clara Unger, Peter Bronsert, Kerstin Michalski, Anna Bicker & Ingolf Juhasz-Böss. (2022) Die Expression des prostataspezifischen Membranantigens (PSMA) beim Mammakarzinom. TumorDiagnostik & Therapie 43:03, pages 187-196.
Crossref
Crossref
Muhammad Tufail & Changxin Wu. (2022) Targeting the IGF-1R in prostate and colorectal cancer: reasons behind trial failure and future directions. Therapeutic Delivery 13:3, pages 167-186.
Crossref
Crossref
Fahad Marafi, Abdulredha Esmail & Sharjeel Usmani. (2022) Prostate-Specific Membrane Antigen Expression in Metastatic Angiosarcoma Detected on 18F-PMSA PET/CT. Clinical Nuclear Medicine 47:2, pages e147-e148.
Crossref
Crossref
Mahasha P.J. Perera, Patrick B. Thomas, Gail P. Risbridger, Renea Taylor, Arun Azad, Michael S. Hofman, Elizabeth D. Williams & Ian Vela. (2022) Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer. Cancers 14:3, pages 503.
Crossref
Crossref
SafaaM M Abd El Khalek & FatmaS Hafez. (2022) Prostate-specific membrane antigen expression in clear-cell renal cell carcinoma: An angiogenic marker with clinicopathologic significance. Egyptian Journal of Pathology 42:1, pages 11.
Crossref
Crossref
Clara Unger, Peter Bronsert, Kerstin Michalski, Anna Bicker & Ingolf Juhasz-Böss. (2022) Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer. Geburtshilfe und Frauenheilkunde 82:01, pages 50-58.
Crossref
Crossref
Olga Sergeeva, Yifan Zhang, Willian Julian, Arun Sasikumar, Amad Awadallah, Jonathan Kenyon, Wuxian Shi, Maxim Sergeev, Steve Huang, Sandra Sexton, Renuka Iyer, Wei Xin, Norbert Avril, Ernest Ricky Chan & Zhenghong Lee. (2022) Imaging of Tumor-Associated Vascular Prostate-Specific Membrane Antigen in Woodchuck Model of Hepatocellular Carcinoma. Gastro Hep Advances 1:4, pages 631-639.
Crossref
Crossref
M. J. M. Uijen, Y. H. W. Derks, R. I. J. Merkx, M. G. M. Schilham, J. Roosen, B. M. Privé, S. A. M. van Lith, C. M. L. van Herpen, M. Gotthardt, S. Heskamp, W. A. M. van Gemert & J. Nagarajah. (2021) PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports. European Journal of Nuclear Medicine and Molecular Imaging 48:13, pages 4350-4368.
Crossref
Crossref
Ryuta Watanabe, Masashi Maekawa, Takeshi Kiyoi, Mie Kurata, Noriyoshi Miura, Tadahiko Kikugawa, Shigeki Higashiyama & Takashi Saika. (2021) PSMA‐positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic state. The Prostate 81:16, pages 1390-1401.
Crossref
Crossref
Ondrej Vit, Mayank Patel, Zdenek Musil, Igor Hartmann, Zdenek Frysak, Markku Miettinen, Karel Pacak & Jiri Petrak. (2021) Deep Membrane Proteome Profiling Reveals Overexpression of Prostate-Specific Membrane Antigen (PSMA) in High-Risk Human Paraganglioma and Pheochromocytoma, Suggesting New Theranostic Opportunity. Molecules 26:21, pages 6567.
Crossref
Crossref
Sharjeel Usmani, Rashid Rasheed, Fareeda Al Kandari & Najeeb Ahmed. (2021) Occult Bone Metastases From Hepatocellular Carcinoma Detected on 68Ga-PMSA PET/CT. Clinical Nuclear Medicine 46:8, pages 661-663.
Crossref
Crossref
Katharina Kessel, Christof Bernemann, Martin Bögemann & Kambiz Rahbar. (2021) Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management. Cancers 13:14, pages 3556.
Crossref
Crossref
Tatjana Traub-Weidinger, Nina Poetsch, Adelheid Woehrer, Eva-Maria Klebermass, Tatjana Bachnik, Matthias Preusser, Mario Mischkulnig, Barbara Kiesel, Georg Widhalm, Markus Mitterhauser, Marcus Hacker & Oskar Koperek. (2021) PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in 11C-Methionine PET and Survival. Journal of Personalized Medicine 11:7, pages 624.
Crossref
Crossref
Anniina Hyväkkä, Verneri Virtanen, Jukka Kemppainen, Tove J. Grönroos, Heikki Minn & Maria Sundvall. (2021) More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond. Cancers 13:9, pages 2244.
Crossref
Crossref
Venkata Subramanian Krishnaraju, Rajender Kumar, Bhagwant Rai Mittal, Vishal Sharma, Harjeet Singh, Ritambhra Nada, Amanjit Bal, Manish Rohilla, Harmandeep Singh & Surinder S. Rana. (2020) Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue. European Radiology 31:4, pages 2199-2208.
Crossref
Crossref
Yirui Guo, Dingyao Gao, Yinfei Chen, Yu Zhang, Liping Chen, Yong Mao, Chunjing Yu, Ling Qiu & Jianguo Lin. (2021) Preclinical Evaluation of a Fluorine-18 Labeled Probe for the Detection of the Expression of PSMA Level in Cancer. ACS Omega 6:12, pages 8279-8287.
Crossref
Crossref
Jing Zhao, Avan Kader, Dilyana B. Mangarova, Julia Brangsch, Winfried Brenner, Bernd Hamm & Marcus R. Makowski. (2021) Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [68Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters. Cancers 13:6, pages 1404.
Crossref
Crossref
Yang Gao, Hui Zheng, Liangdong Li, Mingtao Feng, Xin Chen, Bin Hao, Zhongwei Lv, Xiaoyan Zhou & Yiqun Cao. (2021) Prostate-Specific Membrane Antigen (PSMA) Promotes Angiogenesis of Glioblastoma Through Interacting With ITGB4 and Regulating NF-κB Signaling Pathway. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jasmin Mettler, Alexander Drzezga, Markus Dietlein, Tim Hucho & Carsten Kobe. (2021) Prostate-Specific Membrane Antigen Uptake in a Peripheral Nerve and Respective Ganglia on 68Ga–Prostate-Specific Membrane Antigen–HBED-CC PET/CT. Clinical Nuclear Medicine 46:1, pages 69-70.
Crossref
Crossref
Li-Xing Chen, Si-Juan Zou, Dan Li, Jian-Yuan Zhou, Zhao-Ting Cheng, Jun Zhao, Yuan-Li Zhu, Dong Kuang & Xiao-Hua Zhu. (2020) Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World Journal of Gastroenterology 26:48, pages 7664-7678.
Crossref
Crossref
Andrey A. Stanzhevsky, Artem A. Mosunov, Larisa Chipiga, Aleksandr V. Vodovatov, Laura Naurzbaeva, Stanislav M. Kushnarenko, Dmitry D. Lavreshov & Anna E. Petrova. (2020) DEVELOPMENT OF THE DESIGN OF THE PRECLINICAL TRIALS OF RADIOPHARMACEUTICALS FOR THE RADIONUCLIDE DIOAGNOSTICS AND THERAPY BASED ON THE AMBA PEPTIDE. Pharmacy Formulas.
Crossref
Crossref
Wei Chen, Zhenghong Lee, Amad Awadallah, Lan Zhou & Wei Xin. (2020) Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions. Diagnostic Pathology 15:1.
Crossref
Crossref
Emmanouil Panagiotidis, Anna Paschali, Xanthi Xourgia & Vassiliki Chatzipavlidou. (2020) False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma. Clinical Nuclear Medicine 45:12, pages 960-961.
Crossref
Crossref
Prasanna Santhanam, Jonathon Russell, Lisa M. Rooper, Paul W. Ladenson, Martin G. Pomper & Steven P. Rowe. (2020) The prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer. Medical Oncology 37:11.
Crossref
Crossref
C. Wetterauer, Helge Seifert, A. Chirindel & G. Nicolas. (2020) Die Rolle der PSMA-PET-CT in der Diagnostik und Therapie des ProstatakarzinomsRôle de la TEP/TDM au PSMA dans le diagnostic et le traitement du cancer prostatique. Urologie in der Praxis 22:3, pages 100-104.
Crossref
Crossref
Jayendrakishore Tanjore Ramanathan, Suvi Lehtipuro, Harri Sihto, József Tóvári, Lilla Reiniger, Vanda Téglási, Judit Moldvay, Matti Nykter, Hannu Haapasalo, Vadim Le Joncour & Pirjo Laakkonen. (2020) Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain. Journal of Cellular and Molecular Medicine 24:12, pages 6916-6927.
Crossref
Crossref
Sofia Carrilho Vaz, Ângelo Silva, Carla Oliveira, Rita Marques, António Galzerano & Mireia Castillo-Martin. (2020) Impact of PSMA PET/CT in prostate cancer patient’s clinical management: a pictorial essay of interesting cases with histologic confirmation. Clinical and Translational Imaging 8:3, pages 207-226.
Crossref
Crossref
James J. Vornov, Diane Peters, Mike Nedelcovych, Kristen Hollinger, Rana Rais & Barbara S. Slusher. (2019) Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain. Neurochemical Research 45:6, pages 1256-1267.
Crossref
Crossref
Niklaus Schaefer, John O. Prior & Margret Schottelius. (2020) From Theranostics to Immunotheranostics: the Concept. Nuclear Medicine and Molecular Imaging 54:2, pages 81-85.
Crossref
Crossref
Chu Xin Ng & Sau Har Lee. (2020) The Potential Use of Anticancer Peptides (ACPs) in the Treatment of Hepatocellular Carcinoma. Current Cancer Drug Targets 20:3, pages 187-196.
Crossref
Crossref
Sharjeel Usmani, Alya'a Sadeq, Fahad Marafi, Abdulredha Esmail, Fareeda al Kandari & Najeeb Ahmed. (2020) 68Ga-PMSA Uptake in the Lung. Clinical Nuclear Medicine 45:2, pages e80-e82.
Crossref
Crossref
P. KorolMDMD, M. TkachenkoProf.Prof. & A. VoloshinMDMD. (2020) 99MTc-PSMA – radionuclide imaging of prostate cancer: an innovative diagnostic direction in nuclear medicine. Radiation Diagnostics, Radiation Therapy:3, pages 26-38.
Crossref
Crossref
Ben T. Copeland, Hassan Shallal, Chentian Shen, Kenneth J. Pienta, Catherine A. Foss & Martin G. Pomper. (2019) Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer. Molecular Imaging and Biology 21:6, pages 1054-1063.
Crossref
Crossref
Aurélie Moreau, Olivia Febvey, Thomas Mognetti, Didier Frappaz & David Kryza. (2019) Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma. Frontiers in Oncology 9.
Crossref
Crossref
Chiara Pozzessere, Maria Bassanelli, Anna Ceribelli, Sazan Rasul, Shuren Li, John O. Prior & Francesco Cicone. (2019) Renal Cell Carcinoma: the Oncologist Asks, Can PSMA PET/CT Answer?. Current Urology Reports 20:11.
Crossref
Crossref
Fahad Marafi, Sharjeel Usmani & Abdulredha Esmail. (2019) 68Ga–Prostate-Specific Membrane Antigen PET/CT in Cholangiocarcinoma. Clinical Nuclear Medicine 44:7, pages e439-e441.
Crossref
Crossref
Subhani M. Okarvi. (2019) Recent developments of prostate-specific membrane antigen (PSMA)-specific radiopharmaceuticals for precise imaging and therapy of prostate cancer: an overview. Clinical and Translational Imaging 7:3, pages 189-208.
Crossref
Crossref
Dian JiaoYu LiFa YangDonghui HanJieheng WuShengjia ShiFeng TianZhangyan GuoWenjin XiGuodong LiAizhi ZhaoAn-Gang YangWeijun QinHe WangWeihong Wen. (2019) Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma. Clinical and Translational Gastroenterology 10:5, pages e00041.
Crossref
Crossref
Mikhail Kesler, Charles Levine, Dov Hershkovitz, Eyal Mishani, Yoram Menachem, Hedva Lerman, Yaniv Zohar, Oren Shibolet & Einat Even-Sapir. (2019)
68
Ga-Labeled Prostate-Specific Membrane Antigen Is a Novel PET/CT Tracer for Imaging of Hepatocellular Carcinoma: A Prospective Pilot Study
. Journal of Nuclear Medicine 60:2, pages 185-191.
Crossref
Crossref
M. D. Poyda, D. V. Ryzhkova & A. A. Stanzhevsky. (2018) <sup>68</sup>GA-PSMA — LABELED BIOMARKER FOR POSITRON EMISSION TOMOGRAPHY (LITERATURE REVIEW). Translational Medicine 5:5, pages 46-52.
Crossref
Crossref
S. Medina-Ornelas Sevastián, O. García-Pérez Francisco, Y. Hernández-Pedro Norma, E. Arellano-Zarate Angélica & L. Abúndiz-López Blanca. (2018) Correlation between molecular tumor volume evaluated with 68 Ga-PSMA PET/CT and prostatic specific antigen (PSA) levels. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 37:4, pages 223-228.
Crossref
Crossref
S. Medina-Ornelas Sevastián, O. García-Pérez Francisco, Y. Hernández-Pedro Norma, E. Arellano-Zarate Angélica & L. Abúndiz-López Blanca. (2018) Correlación entre el volumen molecular tumoral evaluado con PET/TC con 68 Ga-PSMA y los niveles de antígeno prostático específico. Revista Española de Medicina Nuclear e Imagen Molecular 37:4, pages 223-228.
Crossref
Crossref
Heike Endepols, Felix M. Mottaghy, Sakine Simsekyilmaz, Jan Bucerius, Felix Vogt, Oliver Winz, Raphael Richarz, Philipp Krapf, Bernd Neumaier, Boris D. Zlatopolskiy & Agnieszka Morgenroth. (2018) In vivo Molecular Imaging of Glutamate Carboxypeptidase II Expression in Re-endothelialisation after Percutaneous Balloon Denudation in a Rat Model. Scientific Reports 8:1.
Crossref
Crossref
Philipp Backhaus, Benjamin Noto, Nemanja Avramovic, Lena Sophie Grubert, Sebastian Huss, Martin Bögemann, Lars Stegger, Matthias Weckesser, Michael Schäfers & Kambiz Rahbar. (2018) Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging 45:5, pages 860-877.
Crossref
Crossref
J. von Hardenberg, K.-A. Büsing, P. Nuhn & M. Ritter. (2018) Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem ProstatakarzinomThe role of PSMA PET-CT in patients with metastatic prostate cancer. Der Radiologe 58:3, pages 226-232.
Crossref
Crossref
Birthe Heitkötter, Konrad Steinestel, Marcel Trautmann, Inga Grünewald, Peter Barth, Heidrun Gevensleben, Martin Bögemann, Eva Wardelmann, Wolfgang Hartmann, Kambiz Rahbar & Sebastian Huss. (2018) Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid. Oncotarget 9:11, pages 9867-9874.
Crossref
Crossref
Mike Sathekge, Thabo Lengana, Alex Maes, Mariza Vorster, JanRijn Zeevaart, Ismaheel Lawal, Thomas Ebenhan & Christophe Van de Wiele. (2017) 68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans. European Journal of Nuclear Medicine and Molecular Imaging 45:2, pages 226-234.
Crossref
Crossref
Shin-ichiro Hori, Alberto Herrera, John Rossi & Jiehua Zhou. (2018) Current Advances in Aptamers for Cancer Diagnosis and Therapy. Cancers 10:1, pages 9.
Crossref
Crossref
Mariz Kasoha, Clara Unger, Erich-Franz Solomayer, Rainer M. Bohle, Claudia Zaharia, Fadi Khreich, Stefan Wagenpfeil & Ingolf Juhasz-Böss. (2018) Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases. Clinical & Experimental Metastasis 34:8, pages 479-490.
Crossref
Crossref
J. von Hardenberg, K.-A. Büsing, P. Nuhn & M. Ritter. (2017) Die Rolle des PSMA-PET/CT bei Patienten mit metastasiertem ProstatakarzinomThe role of PSMA PET-CT in patients with metastatic prostate cancer. Der Urologe 56:11, pages 1410-1416.
Crossref
Crossref
Lars Henning Schmidt, Birthe Heitkötter, Arik B. Schulze, Christoph Schliemann, Konrad Steinestel, Marcel Trautmann, Alessandro Marra, Ludger Hillejan, Michael Mohr, Georg Evers, Eva Wardelmann, Kambiz Rahbar, Dennis Görlich, Georg Lenz, Wolfgang E. Berdel, Wolfgang Hartmann, Rainer Wiewrodt & Sebastian Huss. (2017) Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer. PLOS ONE 12:10, pages e0186280.
Crossref
Crossref
Michael S. Hofman & Amir Iravani. (2017) Gallium-68 Prostate-Specific Membrane Antigen PET Imaging. PET Clinics 12:2, pages 219-234.
Crossref
Crossref
Mike Sathekge, Thabo Lengana, Moshe Modiselle, Mariza Vorster, JanRijn Zeevaart, Alex Maes, Thomas Ebenhan & Christophe Van de Wiele. (2016) 68Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients. European Journal of Nuclear Medicine and Molecular Imaging 44:4, pages 689-694.
Crossref
Crossref
Leslie Ann Caromile, Kristina DortcheM. Mamunur RahmanChristina L. GrantChristopher Stoddard, Fernando A. FerrerLinda H. Shapiro. (2017) PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Science Signaling 10:470.
Crossref
Crossref
Yang Yang, Shuai Hu, Jie Liu, Yun Cui, Yu Fan, Tianjing Lv, Libo Liu, Jun Li, Qun He, Wenke Han, Wei Yu, Yin Sun & Jie Jin. (2017) CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway. Scientific Reports 7:1.
Crossref
Crossref
Birthe Heitkötter, Marcel Trautmann, Inga Grünewald, Martin Bögemann, Kambiz Rahbar, Heidrun Gevensleben, Eva Wardelmann, Wolfgang Hartmann, Konrad Steinestel & Sebastian Huss. (2016) Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST. Oncotarget 8:3, pages 4268-4276.
Crossref
Crossref
Christopher Brian Abraham, Prashant Jani, Roxanne Turuba, Michael Campbell, Ingeborg Zehbe & Laura Curiel. (2017) In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model. Journal of Nanotechnology 2017, pages 1-10.
Crossref
Crossref
Katharina Stock, Konrad Steinestel, Rebekka Wiesch, Jan-Henrik Mikesch, Anna Hansmeier, Marcel Trautmann, Nora Beller, Jan Rehkämper, Eva Wardelmann, Birthe Heitkötter, Wolfgang Hartmann, Jan Sperveslage & Sebastian Huss. (2017) Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma. BioMed Research International 2017, pages 1-8.
Crossref
Crossref
Gerhard Glatting, Carmen Wängler & Björn Wängler. 2017. MR- und PET-Bildgebung der Prostata. MR- und PET-Bildgebung der Prostata
19
56
.
Maria Elisa Perico, Silvia Grasso, Matteo Brunelli, Guido Martignoni, Enrico Munari, Enrico Moiso, Giulio Fracasso, Tiziana Cestari, Hassan Y. Naim, Vincenzo Bronte, Marco Colombatti & Dunia Ramarli. (2016)
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells “
in vitro
” and correlating with progression “
in vivo
”
. Oncotarget 7:45, pages 74189-74202.
Crossref
Crossref
Daniel P. Nguyen, Peter L. Xiong, He Liu, Samuel Pan, Wilhem Leconet, Vincent Navarro, Ming Guo, Jonathan Moy, Sae Kim, Marigdalia K. Ramirez-Fort, Jaspreet S. Batra & Neil H. Bander. (2016) Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment. Molecular Cancer Research 14:11, pages 1045-1053.
Crossref
Crossref
James C Evans, Meenakshi Malhotra, John F Cryan & Caitriona M O'Driscoll. (2016) The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease. British Journal of Pharmacology 173:21, pages 3041-3079.
Crossref
Crossref
Wei Jin, Bin Qin, Zhijin Chen, Hao Liu, Ashutosh Barve & Kun Cheng. (2016) Discovery of PSMA-specific peptide ligands for targeted drug delivery. International Journal of Pharmaceutics 513:1-2, pages 138-147.
Crossref
Crossref
Susanne Lütje, Sebastian Blex, Benedikt Gomez, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Forsting, Walter Jentzen, Andreas Bockisch, Thorsten D. Poeppel & Axel Wetter. (2016) Optimization of Acquisition time of 68Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer. PLOS ONE 11:10, pages e0164392.
Crossref
Crossref
Benjamin Noto, Alexis Vrachimis, Michael Schäfers, Lars Stegger & Kambiz Rahbar. (2016) Subacute Stroke Mimicking Cerebral Metastasis in 68Ga-PSMA-HBED-CC PET/CT. Clinical Nuclear Medicine 41:10, pages e449-e451.
Crossref
Crossref
Rebecca E. Conway, Camilo Rojas, Jesse Alt, Zora Nováková, Spencer M. Richardson, Tori C. Rodrick, Julio L. Fuentes, Noah H. Richardson, Jonathan Attalla, Samantha Stewart, Beshoy Fahmy, Cyril Barinka, Mallika Ghosh, Linda H. Shapiro & Barbara S. Slusher. (2016) Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis 19:4, pages 487-500.
Crossref
Crossref
Rana Rais, Weiwei Jiang, Huihong Zhai, Krystyna M. Wozniak, Marigo Stathis, Kristen R. Hollinger, Ajit G. Thomas, Camilo Rojas, James J. Vornov, Michael Marohn, Xuhang Li & Barbara S. Slusher. (2016) FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities. JCI Insight 1:12.
Crossref
Crossref
Daniel W Binzel, Yi Shu, Hui Li, Meiyan Sun, Qunshu Zhang, Dan Shu, Bin Guo & Peixuan Guo. (2016) Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology. Molecular Therapy 24:7, pages 1267-1277.
Crossref
Crossref
Muraleedharan Parvathy, Sreeharshan Sreeja, Rakesh Kumar & Madhavan Radhakrishna Pillai. (2016) Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells. BMC Cancer 16:S1.
Crossref
Crossref
Wei Jin, Ashutosh Barve & Kun Cheng. (2016) PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy. EMJ Urology, pages 62-69.
Crossref
Crossref
N. Furie, D. Shteynberg, R. Elkhatib, L. Perry, Y. Ullmann, Y. Feferman, M. Preis, M. Y. Flugelman & I. Tzchori. (2016) Fibulin-5 regulates keloid-derived fibroblast-like cells through integrin beta-1. International Journal of Cosmetic Science 38:1, pages 35-40.
Crossref
Crossref
Tânia S.C.R. Rebelo, João P. Noronha, Marco Galésio, Hugo Santos, Mário Diniz, M. Goreti F. Sales, Maria H. Fernandes & João Costa-Rodrigues. (2016) Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface. Materials Science and Engineering: C 59, pages 1069-1078.
Crossref
Crossref
Robyn Bradbury, Wen G Jiang & Yu-Xin Cui. (2015) The clinical and therapeutic uses of MDM2 and PSMA and their potential interaction in aggressive cancers. Biomarkers in Medicine 9:12, pages 1353-1370.
Crossref
Crossref
Fouad Aoun, Hampig Raphael Kourie, Carlos Artigas & Thierry Roumeguère. (2015) Next revolution in molecular theranostics: personalized medicine for urologic cancers. Future Oncology 11:15, pages 2205-2219.
Crossref
Crossref
Hai-long Wang, Shao-shan Wang, Wen-hui Song, Yi Pan, Hai-peng Yu, Tong-guo Si, Yong Liu, Xiao-nan Cui & Zhi Guo. (2015) Expression of Prostate-Specific Membrane Antigen in Lung Cancer Cells and Tumor Neovasculature Endothelial Cells and Its Clinical Significance. PLOS ONE 10:5, pages e0125924.
Crossref
Crossref
Stephen P. Santoro, Soorin Kim, Gregory T. Motz, Dimitrios Alatzoglou, Chunsheng Li, Melita Irving, Daniel J. PowellJrJr & George Coukos. (2015) T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression. Cancer Immunology Research 3:1, pages 68-84.
Crossref
Crossref
Natsuko Nomura, Sandra Pastorino, Pengfei Jiang, Gage Lambert, John R Crawford, Marco Gymnopoulos, David Piccioni, Tiffany Juarez, Sandeep C Pingle, Milan Makale & Santosh Kesari. (2014) Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases. Cancer Cell International 14:1.
Crossref
Crossref
J. Tykvart, V. Navrátil, F. Sedlák, E. Corey, M. Colombatti, G. Fracasso, F. Koukolík, C. Bařinka, P. Šácha & J. Konvalinka. (2014) Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA). The Prostate 74:16, pages 1674-1690.
Crossref
Crossref
Vittorio de Franciscis. (2014) A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer. Molecular Therapy 22:11, pages 1886-1888.
Crossref
Crossref
Justin P Dassie, Luiza I Hernandez, Gregory S Thomas, Matthew E Long, William M Rockey, Craig A Howell, Yani Chen, Frank J Hernandez, Xiu Ying Liu, Mary E Wilson, Lee-Ann Allen, Daniel A Vaena, David K Meyerholz & Paloma H Giangrande. (2014) Targeted Inhibition of Prostate Cancer Metastases with an RNA Aptamer to Prostate-specific Membrane Antigen. Molecular Therapy 22:11, pages 1910-1922.
Crossref
Crossref
Mona Abdel-Hadi, Yasser Ismail & Layla Younis. (2014) Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in Egyptian patients. Pathology - Research and Practice 210:11, pages 759-763.
Crossref
Crossref
A. Ben Jemaa, Y. Bouraoui, S. Sallami, A. Banasr, Y. Nouira & R. Oueslati. (2014) PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer. Pathologie Biologie 62:3, pages 129-136.
Crossref
Crossref
David Bates, Suraj Abraham, Michael Campbell, Ingeborg Zehbe & Laura Curiel. (2014) Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging. PLoS ONE 9:5, pages e97220.
Crossref
Crossref
Tomáš Knedlík, Václav Navrátil, Viktor Vik, Dalibor Pacík, Pavel Šácha & Jan Konvalinka. (2014) Detection and quantitation of glutamate carboxypeptidase II in human blood. The Prostate 74:7, pages 768-780.
Crossref
Crossref
Baohua Huang, James Otis, Melvin Joice, Alina Kotlyar & Thommey P. Thomas. (2014) PSMA-Targeted Stably Linked “Dendrimer-Glutamate Urea-Methotrexate” as a Prostate Cancer Therapeutic. Biomacromolecules 15:3, pages 915-923.
Crossref
Crossref
Petr Busek, Martin Prevorovsky, Evzen Krepela & Aleksi Sedo. 2014. Glioma Cell Biology. Glioma Cell Biology
317
395
.
Julie L. Kasperzyk, Stephen P. Finn, Richard Flavin, Michelangelo Fiorentino, Rosina Lis, Whitney K. Hendrickson, Steven K. Clinton, Howard D. Sesso, Edward L. Giovannucci, Meir J. Stampfer, Massimo Loda & Lorelei A. Mucci. (2013) Prostate-Specific Membrane Antigen Protein Expression in Tumor Tissue and Risk of Lethal Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention 22:12, pages 2354-2363.
Crossref
Crossref
Kevin J. Rycyna, Dean J. Bacich & Denise S. O'Keefe. (2013) Opposing Roles of Folate in Prostate Cancer. Urology 82:6, pages 1197-1203.
Crossref
Crossref
Rebecca E. Conway, Kyle Joiner, Alex Patterson, David Bourgeois, Robert Rampp, Benjamin C. Hannah, Samantha McReynolds, John M. Elder, Hannah Gilfilen & Linda H. Shapiro. (2013) Prostate specific membrane antigen produces pro-angiogenic laminin peptides downstream of matrix metalloprotease-2. Angiogenesis 16:4, pages 847-860.
Crossref
Crossref
Marc ThirietMarc Thiriet. 2013. Tissue Functioning and Remodeling in the Circulatory and Ventilatory Systems. Tissue Functioning and Remodeling in the Circulatory and Ventilatory Systems
605
673
.
Philipp Wolf. 2013. Antibody-Drug Conjugates and Immunotoxins. Antibody-Drug Conjugates and Immunotoxins
255
272
.
Liang-Yun Zhao, Xiao-Peng Mao, Kai-Yuan Chao, Sheng-Jie Guo & Shao-Peng Qiu. (2012) Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice. Brazilian Journal of Medical and Biological Research 45:8, pages 737-745.
Crossref
Crossref
Michael C Haffner, Johannes Laimer, Alcides Chaux, Georg Schäfer, Peter Obrist, Andrea Brunner, Irmgard E Kronberger, Klaus Laimer, Bora Gurel, Johann-Benedikt Koller, Christof Seifarth, Bettina Zelger, Helmut Klocker, Michael Rasse, Wolfgang Doppler & Neil H Bander. (2012) High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity. Modern Pathology 25:8, pages 1079-1085.
Crossref
Crossref
Christina L. Grant, Leslie A. Caromile, Khayyam Durrani, M. Mamunur Rahman, Kevin P. Claffey, Guo-Hua Fong & Linda H. Shapiro. (2012) Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization. PLoS ONE 7:7, pages e41285.
Crossref
Crossref
J. Tykvart, P. Šácha, C. Bařinka, T. Knedlík, J. Starková, J. Lubkowski & J. Konvalinka. (2012) Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: Expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II. Protein Expression and Purification 82:1, pages 106-115.
Crossref
Crossref
Jeroen R Mesters & Rolf Hilgenfeld. 2011. Encyclopedia of Inorganic and Bioinorganic Chemistry. Encyclopedia of Inorganic and Bioinorganic Chemistry.
Bamidele A Adesunloye & William L Dahut. (2011) Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials. Clinical Investigation 1:12, pages 1651-1661.
Crossref
Crossref
Klára Hlouchová, Cyril BaŘinka & Jan Konvalinka. 2011. Proteinases as Drug Targets. Proteinases as Drug Targets
62
95
.
Mary K Samplaski, Warren Heston, Paul Elson, Cristina Magi-Galluzzi & Donna E Hansel. (2011) Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Modern Pathology 24:11, pages 1521-1529.
Crossref
Crossref
Zhiyong Qiu, David C. Diamond, Kent A. Smith, Dar Rosario, Sabrina Miles, Mihail Obrocea, Thomas M. Kundig & Adrian Bot. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice
103
125
.
Awatef Ben Jemaa, Yosra Bouraoui, Sataa Sallami, Ahmed Banasr, Nawfel Ben Rais, Latifa Ouertani, Yassin Nouira, Ali Horchani & Ridha Oueslati. (2010) Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Crossref
Nirupama Deshpande, Marybeth A. Pysz & Jürgen K. Willmann. (2010) Molecular ultrasound assessment of tumor angiogenesis. Angiogenesis 13:2, pages 175-188.
Crossref
Crossref
Kriston L. McGaryTae Joo Park, John O. WoodsHye Ji ChaJohn B. Wallingford & Edward M. Marcotte. (2010) Systematic discovery of nonobvious human disease models through orthologous phenotypes. Proceedings of the National Academy of Sciences 107:14, pages 6544-6549.
Crossref
Crossref
Beatriz del Valle-Pérez, Vanesa Gabriela Martínez, Cristina Lacasa-Salavert, Agnès Figueras, Sandor S. Shapiro, Toshiro Takafuta, Oriol Casanovas, Gabriel Capellà, Francesc Ventura & Francesc Viñals. (2010) Filamin B Plays a Key Role in Vascular Endothelial Growth Factor-induced Endothelial Cell Motility through Its Interaction with Rac-1 and Vav-2. Journal of Biological Chemistry 285:14, pages 10748-10760.
Crossref
Crossref
Veronica Yao, Clifford E. Berkman, Joseph K. Choi, Denise S. O'Keefe & Dean J. Bacich. (2010) Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. The Prostate 70:3, pages 305-316.
Crossref
Crossref
Yong Li & Paul J. Cozzi. (2010) Angiogenesis as a strategic target for prostate cancer therapy. Medicinal Research Reviews 30:1, pages 23-66.
Crossref
Crossref
Michael C. Haffner, Irmgard E. Kronberger, Jeffrey S. Ross, Christine E. Sheehan, Matthias Zitt, Gilbert Mühlmann, Dietmar Öfner, Bettina Zelger, Christian Ensinger, Ximing J. Yang, Stephan Geley, Raimund Margreiter & Neil H. Bander. (2009) Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Human Pathology 40:12, pages 1754-1761.
Crossref
Crossref
Wenle Wang, Fabio Tavora, Rajni Sharma, Mario Eisenberger & George J. Netto. (2009) PSMA expression in Schwannoma: A potential clinical mimicker of metastatic prostate carcinoma. Urologic Oncology: Seminars and Original Investigations 27:5, pages 525-528.
Crossref
Crossref
Klara Hlouchova, Cyril Barinka, Jan Konvalinka & Jacek Lubkowski. (2009) Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III. FEBS Journal 276:16, pages 4448-4462.
Crossref
Crossref
Patrick BühlerPhilipp WolfUrsula Elsässer-Beile. (2009) Targeting the prostate-specific membrane antigen for prostate cancer therapy. Immunotherapy 1:3, pages 471-481.
Crossref
Crossref
Mei-Hsiu Pan, Dong-Wei Gao, Jinjin Feng, Jiang He, Youngho Seo, John Tedesco, John G. Wolodzko, Bruce H. Hasegawa & Benjamin L. Franc. (2008) Biodistributions of 177Lu- and 111In-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of 111In-7E11 as a Pre-therapeutic Agent for 177Lu-7E11 Radioimmunotherapy. Molecular Imaging and Biology 11:3, pages 159-166.
Crossref
Crossref
Marco Colombatti, Silvia Grasso, Alessandra Porzia, Giulio Fracasso, Maria Teresa Scupoli, Sara Cingarlini, Ornella Poffe, Hassan Y. Naim, Martin Heine, Giuseppe Tridente, Fabrizio Mainiero & Dunia Ramarli. (2009) The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways1. PLoS ONE 4:2, pages e4608.
Crossref
Crossref
Taihua Liu, Defang Liu, Yihua Chen, Zonghai Hu, Lu Chen, Chen Luo & Zhejuan Xu. (2009) CD13/APN expression in peripheral blood lymphocytes and skin lesions in patients with advanced psoriasis vulgaris. Journal of Medical Colleges of PLA 24:1, pages 25-30.
Crossref
Crossref
Vivek P. Singh, Kenneth M. Baker & Rajesh Kumar. 2009. The Local Cardiac Renin-Angiotensin Aldosterone System. The Local Cardiac Renin-Angiotensin Aldosterone System
75
89
.
Tiancheng Liu, Yoko Toriyabe, Marat Kazak & Clifford E. Berkman. (2008) Pseudoirreversible Inhibition of Prostate-Specific Membrane Antigen by Phosphoramidate Peptidomimetics. Biochemistry 47:48, pages 12658-12660.
Crossref
Crossref
Ilyssa O Gordon, Maria S Tretiakova, Amy E Noffsinger, John Hart, Victor E Reuter & Hikmat A Al-Ahmadie. (2008) Prostate-specific membrane antigen expression in regeneration and repair. Modern Pathology 21:12, pages 1421-1427.
Crossref
Crossref
Veronica Yao, Anil Parwani, Christoph Maier, Warren DeWayne Heston & Dean John Bacich. (2008) Moderate Expression of Prostate-Specific Membrane Antigen, a Tissue Differentiation Antigen and Folate Hydrolase, Facilitates Prostate Carcinogenesis. Cancer Research 68:21, pages 9070-9077.
Crossref
Crossref
Jeroen R Mesters & Rolf Hilgenfeld. 2006. Handbook of Metalloproteins. Handbook of Metalloproteins.
Benjamin Terrier, Mathieu C. Tamby, Luc Camoin, Philippe Guilpain, Cédric Broussard, Guillaume Bussone, Azzedine Yaïci, Françoise Hotellier, Gérald Simonneau, Loïc Guillevin, Marc Humbert & Luc Mouthon. (2008) Identification of Target Antigens of Antifibroblast Antibodies in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine 177:10, pages 1128-1134.
Crossref
Crossref
Miroslava Rovenská, Klára Hlouchová, Pavel Šácha, Petra Mlčochová, Vratislav Horák, Josef Zámečník, Cyril Bařinka & Jan Konvalinka. (2008) Tissue expression and enzymologic characterization of human prostate specific membrane antigen and its rat and pig orthologs. The Prostate 68:2, pages 171-182.
Crossref
Crossref
Lisa Y. Wu, Jacinda C. Do, Marat Kazak, Helen Page, Yoko Toriyabe, Marc O. Anderson & Clifford E. Berkman. (2008) Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen. Bioorganic & Medicinal Chemistry Letters 18:1, pages 281-284.
Crossref
Crossref
A. Jakobovits. 2008. Therapeutic Antibodies. Therapeutic Antibodies
237
256
.
Serge MoffettDominic MélançonGregory DeCrescenzoCaroline St-PierreFrançois DeschénesH. Uri SaragoviPhil GoldA. Claudio Cuello. (2007) Preparation and Characterization of New Anti-PSMA Monoclonal Antibodies with Potential Clinical Use. Hybridoma 26:6, pages 363-372.
Crossref
Crossref
Lisa Y. Wu, Marc O. Anderson, Yoko Toriyabe, Jack Maung, Tammy Y. Campbell, Cheryl Tajon, Marat Kazak, Jamie Moser & Clifford E. Berkman. (2007) The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen. Bioorganic & Medicinal Chemistry 15:23, pages 7434-7443.
Crossref
Crossref
Kai-Yuan Cao, Xiao-Peng Mao, Dao-Hu Wang, Lin Xu, Guang-Qing Yuan, Shu-Qin Dai, Bo-Jian Zheng & Shao-Peng Qiu. (2007) High expression of PSM-E correlated with tumor grade in prostate cancer: A new alternatively spliced variant of prostate-specific membrane antigen. The Prostate 67:16, pages 1791-1800.
Crossref
Crossref
Xinning Wang, Lihong Yin, Pravin Rao, Robert Stein, Kelley M. Harsch, Zhenghong Lee & Warren D.W. Heston. (2007) Targeted treatment of prostate cancer. Journal of Cellular Biochemistry 102:3, pages 571-579.
Crossref
Crossref
Takashi Tsukamoto, Krystyna M. Wozniak & Barbara S. Slusher. (2007) Progress in the discovery and development of glutamate carboxypeptidase II inhibitors. Drug Discovery Today 12:17-18, pages 767-776.
Crossref
Crossref
Michael J. Morris, Neeta Pandit-Taskar, Chaitanya R. Divgi, Samantha Bender, Joseph A. O'Donoghue, Angelo Nacca, Peter Smith-Jones, Lawrence Schwartz, Susan Slovin, Ronald Finn, Steven Larson & Howard I. Scher. (2007) Phase I Evaluation of J591 as a Vascular Targeting Agent in Progressive Solid Tumors. Clinical Cancer Research 13:9, pages 2707-2713.
Crossref
Crossref
Rebecca Conway, Wolfgang Schacke & Linda Shapiro. (2006) Folh1. AfCS-Nature Molecule Pages.
Crossref
Crossref